MeSH D019643 - replacement arthroplasty
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D019643:
Replacement arthroplasty
D000072228:Replacement arthroplasty shoulder
0 Companies
0 Drugs
Success rate
D019644:Replacement arthroplasty hip
0 Companies
0 Drugs
Success rate
D019645:Replacement arthroplasty knee
0 Companies
0 Drugs
Success rate
D058737:Replacement arthroplasty ankle
0 Companies
0 Drugs
Success rate
D059145:Total disc replacement
0 Companies
0 Drugs
Success rate
D062785:Hemiarthroplasty
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Accord Healthcare | Dabigatran etexilate | Dabigatran Etexilate Accord | 2023-05-26 | |||
| Boehringer Ingelheim | Dabigatran etexilate | Pradaxa | 2008-03-17 |
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
0%0/0
Phase 3
100%3/3
Approved: 3Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use